title: Febrile seizures: risks, evaluation, and prognosis.
abstract: Febrile seizures are common in the first five years of life, and many factors that increase seizure risk have been identified. Initial evaluation should determine whether features of a complex seizure are present and identify the source of fever. Routine blood tests, neuroimaging, and electroencephalography are not recommended, and lumbar puncture is no longer recommended in patients with uncomplicated febrile seizures. In the unusual case of febrile status epilepticus, intravenous lorazepam and buccal midazolam are first-line agents. After an initial febrile seizure, physicians should reassure parents about the low risk of long-term effects, including neurologic sequelae, epilepsy, and death. However, there is a 15 to 70 percent risk of recurrence in the first two years after an initial febrile seizure. This risk is increased in patients younger than 18 months and those with a lower fever, short duration of fever before seizure onset, or a family history of febrile seizures. Continuous or intermittent antiepileptic or antipyretic medication is not recommended for the prevention of recurrent febrile seizures.
authors.affiliation: Baylor Family Medicine Residency Program, Garland, TX 75042, USA. reese.graves@baylorhealth.edu
authors.forename: Reese C
authors.initials: RC
authors.lastname: Graves
authors.forename: Karen
authors.initials: K
authors.lastname: Oehler
authors.forename: Leslie E
authors.initials: LE
authors.lastname: Tingle
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use; D058633:Antipyretics / Q000627:therapeutic use; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012008:Recurrence; D012307:Risk Factors; D003294:Seizures, Febrile / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control
chemical_list: D000927:Anticonvulsants; D058633:Antipyretics